Skip to main content
Top
Published in: Archives of Virology 12/2010

01-12-2010 | Original Article

Variability of the S gene of hepatitis B virus in southeastern China

Authors: Jianjun Niu, Shuizhen He, Chenghao Su, Quan Yuan, Qingrui Chen, Jiguo Chen, Ningshao Xia

Published in: Archives of Virology | Issue 12/2010

Login to get access

Abstract

In a study of 315 HBV specimens obtained from southern China, 240 (76.9%) were assigned to genotype B, 72 (22.9%) were genotype C, two (0.6%) were genotype A and one (0.3%) was genotype D. Statistical analysis revealed that variables such as age, gender, HBV vaccination rate, hepatitis anamnesis rate, anti-HBs and HBeAg prevalence and virus load were insignificant between genotype B (n = 240) and genotype C cases (n = 72) (P > 0.05). However, the frequency of amino acid (aa) substitutions in the major hydrophilic region (MHR; aa 99–169) and the putative HLA class I-restricted cytotoxic T lymphocyte (CTL) epitope region of the S gene, as well as the overlapping polymerase/RT region (aa 32–212), were significantly higher in genotype C group than genotype B (P < 0.001). These results suggest that the higher variability within genotype C carriers may account for the pathogenic potential.
Literature
1.
go back to reference Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329CrossRefPubMed Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329CrossRefPubMed
2.
go back to reference Chen CC, Yuan Q, Ge SX, Ou SH, Ni HY, Zhang YC, Pei B, Li A, Yan Q, Lin YC (2009) Surveillance for occult HBV infection and HBsAg variants in blood donnors. Bing Du Xue Bao 25:178–184PubMed Chen CC, Yuan Q, Ge SX, Ou SH, Ni HY, Zhang YC, Pei B, Li A, Yan Q, Lin YC (2009) Surveillance for occult HBV infection and HBsAg variants in blood donnors. Bing Du Xue Bao 25:178–184PubMed
3.
4.
go back to reference Fares MA, Holmes EC (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54:807–814CrossRefPubMed Fares MA, Holmes EC (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54:807–814CrossRefPubMed
5.
go back to reference Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K (2001) Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027–1034CrossRefPubMed Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K (2001) Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027–1034CrossRefPubMed
6.
go back to reference Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499–1503CrossRefPubMed Hsu HY, Chang MH, Ni YH, Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499–1503CrossRefPubMed
7.
go back to reference Jaoude GA, Sureau C (2005) Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J Virol 79:10460–10466CrossRefPubMed Jaoude GA, Sureau C (2005) Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J Virol 79:10460–10466CrossRefPubMed
8.
go back to reference Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554–559CrossRefPubMed Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554–559CrossRefPubMed
9.
go back to reference Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83:1267–1280PubMed Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83:1267–1280PubMed
10.
go back to reference Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW (2001) Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16:359–362PubMed Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW (2001) Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16:359–362PubMed
11.
go back to reference Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS (2002) Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol 68:50–59CrossRefPubMed Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS (2002) Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol 68:50–59CrossRefPubMed
12.
go back to reference Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309CrossRefPubMed Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309CrossRefPubMed
13.
go back to reference Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80:10307–10314CrossRefPubMed Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80:10307–10314CrossRefPubMed
14.
go back to reference Shizuma T, Hasegawa K, Ishikawa K, Naritomi T, Iizuka A, Kanai N, Ogawa M, Torii N, Joh R, Hayashi N (2003) Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol 38:244–253CrossRefPubMed Shizuma T, Hasegawa K, Ishikawa K, Naritomi T, Iizuka A, Kanai N, Ogawa M, Torii N, Joh R, Hayashi N (2003) Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol 38:244–253CrossRefPubMed
15.
go back to reference Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, Acharya SK, Gish RG, Kramvis A, Shimada T, Izumi N, Kaito M, Miyakawa Y, Mizokami M (2006) Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44:915–924CrossRefPubMed Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, Acharya SK, Gish RG, Kramvis A, Shimada T, Izumi N, Kaito M, Miyakawa Y, Mizokami M (2006) Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44:915–924CrossRefPubMed
16.
go back to reference Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32:102–112CrossRefPubMed Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32:102–112CrossRefPubMed
17.
go back to reference Weber B (2006) Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78(Suppl 1):S59–S65CrossRefPubMed Weber B (2006) Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78(Suppl 1):S59–S65CrossRefPubMed
18.
go back to reference Westover KM, Hughes AL (2007) Evolution of cytotoxic T-lymphocyte epitopes in hepatitis B virus. Infect Genet Evol 7:254–262CrossRefPubMed Westover KM, Hughes AL (2007) Evolution of cytotoxic T-lymphocyte epitopes in hepatitis B virus. Infect Genet Evol 7:254–262CrossRefPubMed
19.
go back to reference Whalley SA, Brown D, Webster GJ, Jacobs R, Reignat S, Bertoletti A, Teo CG, Emery V, Dusheiko GM (2004) Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology 127:1131–1138CrossRefPubMed Whalley SA, Brown D, Webster GJ, Jacobs R, Reignat S, Bertoletti A, Teo CG, Emery V, Dusheiko GM (2004) Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology 127:1131–1138CrossRefPubMed
20.
go back to reference Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH, Yeo AE, Shih JW, Zhang J, Xia NS (2010) Molecular characteristics of occult hepatitis B virus from blood donors in the southeast China. J Clin Microbiol 48:357–362CrossRefPubMed Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH, Yeo AE, Shih JW, Zhang J, Xia NS (2010) Molecular characteristics of occult hepatitis B virus from blood donors in the southeast China. J Clin Microbiol 48:357–362CrossRefPubMed
21.
go back to reference Zhou YH, Wu C, Zhuang H (2009) Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 122:98–102 Zhou YH, Wu C, Zhuang H (2009) Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 122:98–102
Metadata
Title
Variability of the S gene of hepatitis B virus in southeastern China
Authors
Jianjun Niu
Shuizhen He
Chenghao Su
Quan Yuan
Qingrui Chen
Jiguo Chen
Ningshao Xia
Publication date
01-12-2010
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 12/2010
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-010-0786-x

Other articles of this Issue 12/2010

Archives of Virology 12/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.